AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells
S Martín-Vilchez, F Molina-Jiménez, J L Alonso-Lebrero, P Sanz-Cameno, Y Rodríguez-Muñoz, I Benedicto, P Roda-Navarro, M Trapero, L Aragoneses-Fenoll, S González, J P Pivel, A L Corbí, M López-Cabrera, R Moreno-Otero, P L Majano, S Martín-Vilchez, F Molina-Jiménez, J L Alonso-Lebrero, P Sanz-Cameno, Y Rodríguez-Muñoz, I Benedicto, P Roda-Navarro, M Trapero, L Aragoneses-Fenoll, S González, J P Pivel, A L Corbí, M López-Cabrera, R Moreno-Otero, P L Majano
Abstract
Background and purpose: Dendritic cells (DCs) are dedicated antigen-presenting cells able to initiate specific immune responses and their maturation is critical for the induction of antigen-specific T-lymphocyte responses. Here, we have investigated the effects of Inmunoferon-active principle (AM3), the active agent of a commercial immunomodulatory drug, on human monocyte-derived DCs (MDDCs).
Experimental approach: MDDCs derived from healthy and hepatitis C virus (HCV)-infected patients were stimulated with AM3. We analysed the expression of cell surface proteins by flow cytometry, that of cytokine production by ELISA, and the expression of chemokines and chemokine receptors by RNase protection assays. T-lymphocyte proliferation was assessed in mixed lymphocyte reactions, protein expression by western blot and luciferase-based reporter methods, and Toll-like receptor (TLR)-blocking antibodies were employed to analyse TLR activity.
Key results: In MDDCs, AM3 induced or enhanced expression of CD54, CD83, CD86, HLA-DR, chemokines and chemokine receptors, interleukin (IL)-12p70 and IL-10. Furthermore, AM3 stimulated MDDCs to increase proliferation of allogenic T cells. AM3 triggered nuclear translocation of NF-kappaB and phosphorylation of p38 mitogen-activated protein kinase. AM3 promoted NF-kappaB activation in a TLR-4-dependent manner, and blocking TLR-4 activity attenuated the enhanced expression of CD80, CD83 and CD86 induced by AM3. AM3 enhanced the expression of maturation-associated markers in MDDCs from HCV-infected patients and increased the proliferation of T lymphocytes induced by these MDDCs.
Conclusions and implications: These results underline the effects of AM3 in promoting maturation of MDDCs and suggest that AM3 might be useful in regulating immune responses in pathophysiological situations requiring DC maturation.
Figures
References
- Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T, et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol. 2003;171:4984–4989.
- An H, Yu Y, Zhang M, Xu H, Qi R, Yan X, et al. Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology. 2002;106:38–45.
- Ardeshna KM, Pizzey AR, Devereux S, Khwaja A. The PI3 kinase, p38 SAP kinase, and NF-kB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood. 2000;96:1039–1047.
- Arrighi JF, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-α, and contact sensitizers. J Immunol. 2001;166:3837–3845.
- Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97:3171–3176.
- Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 2001;120:512–524.
- Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811.
- Brieva A, Guerrero A, Alonso-Lebrero JL, Pivel JP. Immunoferon, a glycoconjugate of natural origin, inhibits LPS-induced TNF-alpha production and inflammatory responses. Int Immuno pharmacol. 2001;1:1979–1983.
- Brieva A, Guerrero A, Pivel JP. Inmunoferon, an immunomodulator of natural origin, does not affect the rat liver cytochrome P-450 and phase II conjugation enzymes. Methods Find Exp Clin Pharmacol. 2003;25:187–191.
- Camacho F, Elorza FL, Ortega M, Elorza MA, Sada G, Villarrubia VG. [AM3 (a biological response modifier) in the treatment of recurrent aphthous stomatitis. Clinical evaluation and preliminary studies on NK (CD16) cells and their pathogenic role in the syndrome] Rev Clin Esp. 1991;188:403–408.
- Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol. 1997;9:10–16.
- Corinti S, Albanesi C, la Sala A, Pastore S, Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol. 2001;166:4312–4318.
- de Saint-Vis B, Fugier-Vivier I, Massacrier C, Gaillard C, Vanbervliet B, Ait-Yahia S, et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol. 1998;160:1666–1676.
- Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol. 1998;16:495–521.
- Gremion C, Cerny A. Hepatitis C virus and the immune system: a concise review. Rev Med Virol. 2005;15:235–268.
- Guerrero A, Brieva A, Pivel JP. A new method for radioiodination of polysaccharides and its use in biodistribution studies of an immunomodulating glycoconjugate (Immunoferon) Methods Find Exp Clin Pharmacol. 2000;22:621–625.
- Kalinski P, Hilkens CM, Wierenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarixed dendritic cells: the concept of a third signal. Immunol Today. 1999;20:561–567.
- Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584–5591.
- Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular patho genesis of endotoxic shock and organ failure. Mol Med Today. 1999;5:123–132.
- Langenkamp A, Messi M, Lanzavecchia A, Sallusto F. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol. 2000;1:311–316.
- Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood. 2004;103:1026–1029.
- Majano P, Alonso-Lebrero JL, Janczyk A, Martin-Vichez S, Molina-Jimenez F, Brieva A, et al. AM3 inhibits LPS-induced iNOS expression in mice. Int Immunopharmacol. 2005;5:1165–11670.
- Majano P, Roda-Navarro P, Alonso-Lebrero JL, Brieva A, Casal C, Pivel JP, et al. AM3 inhibits HBV replication through activation of peripheral blood mononuclear cells. Int Immunopharmacol. 2004;4:921–927.
- Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.
- Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004;25:75–84.
- Neumann M, Fries HW, Scheicher C, Keikavoussi P, Kolb-Maürer A, Bröcker EB, et al. Differential expression of Rel/NF-kB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood. 2000;95:277–285.
- Pachiadakis I, Pollara G, Chain BM, Naoumov NV. Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence. Lancet Infect Dis. 2005;5:296–304.
- Pantoja-Uceda D, Bruix M, Gimenez-Gallego G, Rico M, Santoro J. Solution structure of RicC3, a 2S albumin storage protein from Ricinus communis. Biochemistry. 2003;42:13839–13847.
- Pantoja-Uceda D, Bruix M, Santoro J, Rico M, Monsalve R, Villalba M. Solution structure of allergenic 2S albumins. Biochem Soc Trans. 2002;30 Part 6:919–924.
- Perez-García R, Perez-Garcia A, Verbeelen D, Bernstein ED, Villarrubia VG, Alvarez-Mon M. AM3 (Inmunoferon) as an adjuvant to hepatitis B vaccination in hemodialysis patients. Kidney Int. 2002;61:1845–1852.
- Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet. 2003;362:2095–2100.
- Prieto A, Reyes E, Bernstein ED, Martinez B, Monserrat J, Izquierdo JL, et al. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon) Am J Respir Crit Care Med. 2001;163:1578–1583.
- Puig-Kröger A, Relloso M, Fernandez-Capetillo O, Zubiaga A, Silva A, Bernabeu C, et al. Extracellular signal-regulated protein kinase signalling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood. 2001;98:2175–2182.
- Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001;276:37692–37699.
- Reyes E, Prieto A, de la Hera A, de Lucas P, Alvarez-Sala R, Alvarez-Sala JL, et al. Treatment with AM3 restores defective T-cell function in COPD patients. Chest. 2006;129:527–535.
- Rimoldi M, Rescigno M. Uptake and presentation of orally administered antigens. Vaccine. 2005;23:1793–1796.
- Rojo JM, Rejas MT, Ojeda G, Portoles P, Barasoain I. Enhancement of lymphocyte proliferation, interleukin-2 production and NK activity by inmunoferon (AM-3), a fungal immunomodulator: variations in normal and immunosuppressed mice. Int J Immunopharmacol. 1986;8:593–597.
- Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–1118.
- Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, et al. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol. 1999;29:1617–1625.
- Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol. 1998;28:2760–2769.
- Sanchez L, Pena E, Civantos A, Sada G, Alvarez MM, Chirigos MA, et al. AM3, an adjuvant to hepatitis B revaccination in non-responder healthy persons. J Hepatol. 1995;22:119–121.
- Sánchez Palacios A, Garcia Marrero JA, Schamann F. Immunologic clinical evaluation of a biological response modifier, AM3, in the treatment of childhood infectious respiratory pathology. Allergol Immunopathol. 1992;20:35–39.
- Sato K, Nagayama H, Tadokoro K, Juji T, Takahashi TA. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-a-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J Immunol. 1999;162:3865–3872.
- Serrano-Gomez D, Martinez-Nunez RT, Sierra-Filardi E, Izquierdo N, Colmenares M, Pla J, et al. Inmunoferon modulates dendritic cell pathogen-recognition capabilities by targeting DC-SIGN. Antimicrob Agents Chemother. 2007;51:2313–2323.
- Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335–376.
- Varela J, Navarro-Pico ML, Guerrero A, Garcia F, Gimenez-Gallego G, Pivel JP. Identification and characterization of the peptidic component of the immunomodulatory glycoconjugate immunoferon. Methods Find Exp Clin Pharmacol. 2002;24:471–480.
- Villarrubia VG, Moreno Koch MC, Calvo C, González S, Alvarez-Mon M. The immunosenescent phenotype in mice and humans can be defined by alterations in the natural immunity reversal by immunomodulation with oral AM3. Immunopharmacol Immunotoxicol. 1997;19:53–74.
- Villarrubia VG, Valladolid JM, Elorza FL, Sada G, Vilchez JG, Jimenez M, et al. Therapeutic response of chronic active hepatitis B to a new immunomodulator: AM3. Immunohematological effects. Immunopharmacol Immunotoxicol. 1992;14:141–164.
- Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israel A, Kourilsky P. Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J. 1987;6:3317–3324.
Source: PubMed